Home › Agent Hub › Agent Tools › Part D coverage by drug › NovoLog
Agent Tools
NovoLog is a brand of insulin aspart, human. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 4,542 of 5,492 Medicare Part D and Medicare Advantage drug plans (82.7%) list NovoLog on their formulary, across 212 of 286 formularies. The most common placement is tier 3 (4,262 plans, 93.8% of those covering it). 0 of the covering plans require prior authorization (0%), 0 step therapy and 330 a quantity limit. Generic insulin aspart, human is on 5,262 of 5,492 plans (95.8%).
442 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $22.50, 178 of them $0; 4,100 charge coinsurance instead — median 20% of the drug's cost. Covered insulin is capped at $35 for a month's supply.
NovoLog has a Medicare negotiated price (maximum fair price) of $119 for a 30-day supply, which applies. The negotiated price lowers what the plan pays; the member's copay or coinsurance still follows the plan's tier.
2026: 5,496 of 5,496 plans covered it (100%); 2027: 4,542 of 5,492 (82.7%).
Of 4,367 plans offered in both years, 0 added it to the formulary and 772 dropped it.
Among plans covering it both years, 35 moved it to a higher tier and 18 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 106 |
| Tier 2 | 144 |
| Tier 3 | 4,262 |
| Tier 5 | 10 |
| Tier 6 | 20 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 243 of 323 | 75.2% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,576 of 3,200 | 80.5% | 0% |
| Special needs plans (SNP) | 1,723 of 1,969 | 87.5% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 846 of 846 | Tier 3 | 0 |
| UnitedHealthcare | 830 of 830 | Tier 3 | 0 |
| Devoted Health | 728 of 728 | Tier 3 | 0 |
| Aetna Medicare | 631 of 631 | Tier 3 | 0 |
| Wellcare | 0 of 268 | No tier listed | 0 |
| HealthSpring | 226 of 226 | Tier 3 | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 0 of 83 | No tier listed | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 0 of 80 | No tier listed | 0 |
| Alignment Health Plan | 77 of 77 | Tier 3 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 3 | 0 |
| Wellpoint | 63 of 63 | Tier 3 | 0 |
| Priority Health Medicare | 0 of 40 | No tier listed | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 2 | 0 |
| Zing Health | 36 of 36 | Tier 3 | 0 |
| Capital Blue Cross | 27 of 35 | Tier 3 | 0 |
| Prominence Health Plan | 29 of 29 | Tier 3 | 0 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 3 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 3 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 107 of 114 | 93.9% |
| Alaska | 7 of 9 | 77.8% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 129 of 147 | 87.8% |
| Arkansas | 77 of 85 | 90.6% |
| California | 244 of 397 | 61.5% |
| Colorado | 93 of 106 | 87.7% |
| Connecticut | 48 of 54 | 88.9% |
| Delaware | 35 of 43 | 81.4% |
| District of Columbia | 9 of 12 | 75% |
| Florida | 461 of 545 | 84.6% |
| Georgia | 126 of 149 | 84.6% |
| Guam | 1 of 1 | 100% |
| Hawaii | 42 of 50 | 84% |
| Idaho | 40 of 45 | 88.9% |
| Illinois | 112 of 132 | 84.8% |
| Indiana | 131 of 138 | 94.9% |
| Iowa | 57 of 64 | 89.1% |
| Kansas | 73 of 84 | 86.9% |
| Kentucky | 110 of 121 | 90.9% |
| Louisiana | 113 of 125 | 90.4% |
| Maine | 46 of 52 | 88.5% |
| Maryland | 37 of 49 | 75.5% |
| Massachusetts | 75 of 89 | 84.3% |
| Michigan | 132 of 182 | 72.5% |
| Minnesota | 31 of 63 | 49.2% |
| Mississippi | 89 of 104 | 85.6% |
| Missouri | 155 of 170 | 91.2% |
| Montana | 24 of 27 | 88.9% |
| Nebraska | 40 of 51 | 78.4% |
| Nevada | 89 of 100 | 89% |
| New Hampshire | 23 of 25 | 92% |
| New Jersey | 64 of 73 | 87.7% |
| New Mexico | 63 of 68 | 92.6% |
| New York | 174 of 215 | 80.9% |
| North Carolina | 164 of 176 | 93.2% |
| North Dakota | 17 of 26 | 65.4% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 141 of 171 | 82.5% |
| Oklahoma | 79 of 81 | 97.5% |
| Oregon | 70 of 92 | 76.1% |
| Pennsylvania | 198 of 323 | 61.3% |
| Puerto Rico | 23 of 64 | 35.9% |
| Rhode Island | 22 of 29 | 75.9% |
| South Carolina | 81 of 89 | 91% |
| South Dakota | 19 of 30 | 63.3% |
| Tennessee | 152 of 156 | 97.4% |
| Texas | 369 of 407 | 90.7% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 49 of 53 | 92.5% |
| Vermont | 12 of 14 | 85.7% |
| Virginia | 134 of 144 | 93.1% |
| Washington | 84 of 114 | 73.7% |
| West Virginia | 55 of 69 | 79.7% |
| Wisconsin | 85 of 96 | 88.5% |
| Wyoming | 10 of 13 | 76.9% |
Medicare Part D paid for 3,206,413 30-day fills of NovoLog in 2024 for about 590,683 enrollees, at an average total cost of $121.98 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price NovoLog and the rest of a client's list on every plan in their county.
Estimate NovoLog costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.